|
Market Closed -
OTC Markets
09:30:01 2025-07-17 EDT
|
5-day change | 1st Jan Change | ||
| 0.3000 USD | +20.00% |
|
-.--% | - |
| 08-10 | Nicox Sa and Ocumension Therapeutics Submit Ncx 470 New Drug Application in China | CI |
| 08-10 | Nicox Partner Files China Drug Application for NCX 470 Eye Drop | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- ALCOX Stock
- NICXF Stock
- Consensus Nicox SA
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
